Sign inJoin waitlistJoin the waitlist

JF

Jyotsna Fuloria

Physician · Emory University School of Medicine

Credentials: · · · · ·

History

Emory University School of Medicine
2025–Present

Hematology and Medical Oncology
Internal Medicine

Research

A phase II study of gemcitabine and cisplatin in chemotherapy-naive, unresectable gall bladder cancer
British Journal of Cancer · 2004 · 108 citations
Phase I dose escalation pharmacokinetic assessment of intravenous humanized anti-MUC1 antibody AS1402 in patients with advanced breast cancer
Breast Cancer Research · 2009 · 39 citations
Effect of the cytochrome P450 2C19 inhibitor omeprazole on the pharmacokinetics and safety profile of bortezomib in patients with advanced solid tumours, non-Hodgkin's lymphoma or…
Clinical Pharmacokinetics · 2009 · 33 citations

AG
Ana-Maria Gonzalez-Angulo
2 papers
CL
Charles Loprinzi
2 papers
Leonard Bok
2 papers
Mirandy Li
2 papers
Al Benson
1 paper
AL
Alan Lyss
1 paper
AM
Allen Melemed
1 paper
Amit Keswani
1 paper · 1 as a fellow
AK
Ann Kearns
1 paper
Anthony Jaslowski
1 paper
Anthony Viera
1 paper
Brian Lewis
1 paper

Grants

Ochsner NCI Community Oncology Research Program
National Cancer Institute · UG1
Contact PI · $1.4M · Ochsner Clinic Foundation
2014–2019
Ochsner Community Clinical Oncology Program
National Cancer Institute · U10
Contact PI · $3.2M · Ochsner Clinic Foundation
1983–2016

Clinical trials

Atezolizumab in Combination With a Multi-Kinase Inhibitor for the Treatment of Unresectable, Locally Advanced, or Metastatic Liver Cancer
Site PI · Recruiting · Phase 2
Academic and Community Cancer Research United
2022–2026
TPIV100 and Sargramostim for the Treatment of HER2 Positive, Stage II-III Breast Cancer in Patients With Residual Disease After Chemotherapy and Surgery
Site PI · Unknown · Phase 2
Academic and Community Cancer Research United
2020–2025